Proliferating cell nuclear antigen in endometrial carcinoma: Pretreatment identification of high-risk patients

Gynecologic Oncology

Volumn 61, Issue 1, 1996, Pages 16-21

  Garzetti, Giuseppe G ^a   Ciavattini, Andrea ^a   Goteri, Gaia ^a   De Nictolis, Michele ^a   Romanini, Carlo ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CURETTAGE; DNA DETERMINATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOMETRIUM; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0030009602     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0089     Document Type: Article

References (19)

1. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics, 1992, CA Cancer J. Clin. 42, 19-32 (1992).
2. Vavra, N., Denison, U., Kucera, H., Barrada, M., Kurz, C., Salzer, H., and Sevelda, P. Prognostic factors related to recurrent endometrial carcinoma following initial surgery, Acta Obstet. Gynecol. Scand. 72, 205-209 (1993).
3. Podczaski, E., Kaminski, P., Gurski, K., MacNeill, C., Stryker, J. A., Singapuri, K., Hackett, T. E., Sorosky, J., and Zaino, R. Detection of patters of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery, Gynecol. Oncol. 47, 323-327 (1992).
4. Rotman, M., Aziz, H., Halpern, J., Schwartz, D., Sohn, C., and Choi, K. Endometrial carcinoma: Influence of prognostic factors on radiation management, Cancer 71, 1471-1479 (1993).
5. Sorbe, B., Risberg, B., and Frankendal, B. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma, Gynecol. Oncol. 38, 22-27 (1990).
6. Newbury, R., Scherch, C., Goodspeed, N., Fanning, J., Glidewell, O., and Evans, M. DNA content as a prognostic factor in endometrial carcinoma, Obstet. Gynecol. 76, 251-257 (1990).
7. Britton, L. C., Wilson, T. O., Gaffey, T. A., Lieber, M. M., Wieand, H. S., and Podratz, K. C. Flow cytometric analysis of stage I endometrial carcinoma, Gynecol. Oncol. 34, 317-322 (1989).
8. Rosemberg, P., Wingren, S., Simonsen, E., Stal, O., Risberg, B., and Nordenskjold, B. Flow cytometric measurements of DNA index and S-phase on paraffin embedded early stage endometrial cancer: An important prognostic indicator, Gynecol. Oncol. 35, 50-54 (1989).
9. Charpin, C., Andrac, L., Habib, M. C., Vacheret, H., Lavaut, M. N., Xerri, L., and Toga, M. Immunocytochemical assays in human endometrial carcinomas: A multiparametric computerized analysis and comparison with nonmalignant changes, Gynecol. Oncol. 33, 9-22 (1989).
10. DiSaia, P. J., and Creasman, W. T. Clinical gynecologic oncology, third ed., Mosby, St. Louis/Washington, DC/Toronto (1989).
11. Poulsen, H. E., Taylor, S. W., and Sobin, L. H. Histological typing of female genital tract tumours. International histological classification of tumours, World Health Organ. 13, 64-65 (1975).
12. FIGO stages - 1988 revision (Announcement), Gynecol. Oncol. 35, 125-127 (1989).
13. Sahakian, V., Syrop, C., and Turner, D. Endometrial carcinoma: Transvaginal ultrasonography prediction of the depth of myometrial invasion, Gynecol. Oncol. 43, 217-219 (1991).
14. Shim, J. U., Rose, P. G., Reale, F. R., Soto, H., Tak, W. K., and Hunter, R. E. Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma, Am. J. Obstet. Gynecol. 166, 1335-1338 (1992).
15. Fanning, J., Tsukada, Y., and Piver, M. S. Intraoperative frozen-section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma, Gynecol. Oncol. 37, 47-50 (1990).
16. Cowles, T. A., Magrina, J. F., Masterson, B. J., and Capen, C. V. Comparison of clinical and surgical staging in patients with endometrial carcinoma, Obstet. Gynecol. 66, 413-416 (1985).
17. Podratz, K. C., Wilson, T. O., Gaffey, T. A., Cha, S. S., and Katzmann, J. A. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high risk endometrial cancer patients, Am. J. Obstet. Gynecol. 168, 1206-1213 (1993).
18. Khalifa, M. A., Abdoh, A. A., Mannel, R. S., Haraway, S. D., Walker, J. L., and Min, K. W. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma, Cancer 73, 370-376 (1994).
19. Kohler, U., Taubert, G., Bilek, K., et al. The relation between the result of cytophotometric examination of endometrial carcinoma and clinical course of these disease, Arch. Gynecol. Obstet. 252, 93-97 (1992).